Gufic Group Executive and Leadership Team

Devkinandan Roonghta, the Chief Financial Officer at Gufic Group, directs all fiscal planning and capital allocation strategies. Managing the financial health of the organization, the Chief Financial Officer oversees budgetary controls and investment analysis to support the development of advanced pharmaceutical products. This leadership role involves maintaining rigorous compliance standards while optimizing resource distribution across manufacturing facilities. By monitoring market trends and internal performance metrics, Devkinandan Roonghta ensures long-term fiscal stability and sustainable growth. The Chief Financial Officer collaborates with the board to refine capital structures, facilitating the expansion of the company's international footprint. Through precise financial oversight, the Chief Financial Officer secures the necessary funding for research and development initiatives, ultimately strengthening the competitive position of the firm within the global pharmaceutical landscape.

Nagesh Yarrabathina, the Chief Operating Officer at Gufic Group, architects the daily manufacturing processes and production workflows for lyophilized injections. Overseeing the technical operations, the Chief Operating Officer ensures that all pharmaceutical and herbal product lines meet stringent quality benchmarks. This leadership role involves streamlining production cycles to maximize output efficiency across diverse manufacturing sites. By integrating advanced technology into the assembly process, Nagesh Yarrabathina drives operational excellence and minimizes waste. The Chief Operating Officer coordinates with research teams to scale new product launches, ensuring seamless transitions from laboratory development to full-scale commercial production. Through consistent monitoring of operational KPIs, the Chief Operating Officer maintains high standards of safety and efficacy, supporting the company's reputation as a leading manufacturer of critical medical treatments.

Ganesan Krishnamoorthy, the President, Supply Chain Management at Gufic Group, architects the end-to-end logistics network required to distribute pharmaceutical products to major hospital chains. Overseeing the procurement of raw materials and the delivery of finished goods, the President, Supply Chain Management ensures the timely availability of antibiotics, antifungals, and antiviral treatments. This leadership role involves managing complex distribution channels across the national market to maintain consistent supply levels. By optimizing inventory management and logistics partnerships, Ganesan Krishnamoorthy reduces lead times and enhances service reliability. The President, Supply Chain Management coordinates with manufacturing and sales teams to align supply capabilities with market demand. Through rigorous oversight of the supply chain, the President, Supply Chain Management facilitates the company's ability to provide critical medical supplies to leading healthcare facilities, ensuring operational continuity.

Shekhar Aley, the President, Sales & Marketing-Critical Care Sbus Indianepalinneurocare at Gufic Group, directs the commercial strategy for critical care and neurocare product lines. Overseeing the sales force and marketing initiatives, the President, Sales & Marketing-Critical Care Sbus Indianepalinneurocare drives market penetration across major hospital networks. This leadership role involves identifying growth opportunities for specialized pharmaceutical treatments and expanding the reach of the company's portfolio. By analyzing regional market dynamics, Shekhar Aley crafts targeted campaigns that highlight the efficacy of the firm's lyophilized injections. The President, Sales & Marketing-Critical Care Sbus Indianepalinneurocare collaborates with medical professionals to ensure the adoption of advanced therapeutic solutions. Through strategic relationship management with key healthcare stakeholders, the President, Sales & Marketing-Critical Care Sbus Indianepalinneurocare secures a dominant market position, directly contributing to the company's revenue growth and brand recognition.

Sunil Desai, the Chief Human Resources Officer at Gufic Group, directs talent acquisition and organizational development strategies. Managing the workforce lifecycle, the Chief Human Resources Officer fosters a culture of innovation and professional growth across all departments. This leadership role involves designing comprehensive training programs that align employee skills with the evolving needs of the pharmaceutical industry. By implementing performance management systems, Sunil Desai ensures that the workforce remains focused on achieving corporate objectives. The Chief Human Resources Officer collaborates with executive leadership to cultivate a high-performance environment, driving employee engagement and retention. Through strategic workforce planning, the Chief Human Resources Officer supports the company's mission to deliver high-quality medical solutions, ensuring that the organization attracts and retains top-tier talent capable of advancing complex pharmaceutical research and development.